510(k) · Cleared
ClearedDryodine Cadexomer-Iodine Gel
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Collegium Pharmaceutical Incorporated · FRO Dressing, Wound, Drug
Cleared on Jun 18, 2010 as substantially equivalent to K905069 (Perstorp AB C/O Robert Joel Slomoff, 1991) and 1 other predicate after a 238-day review. Its family tree reaches back 2 generations to 1994.
- Decided
- Jun 18, 2010
- Review
- 238 days
- Class
- Class U
- Product code
- FRO
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 2 generations to K940414 (1994). 4 ancestors in all, the oldest K905069 (1991). No later device cites it as a predicate yet.
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K940414 | Iodoflex Paste | Oclassen Pharmaceuticals, Inc. | 1994 | — |
| −1 | K051542 | Triosyn T40 Antimicrobial Wound Dressing | Triosyn Corp. | 2006 | — |
| 0 (this device) | K093320 | Dryodine Cadexomer-Iodine Gel | Collegium Pharmaceutical Incorporated | 2010 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1991 | 1 | 0 |
| 2000 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in FRO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new FRO device
- #1 K261023 Microdacyn Wound Irrigation Solutionscore 15.5 · 14 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K905069 | Iodosorb GelSummary page 1…DryodineTm Antibacterial Gel is substantially equivalent to the following predicate devices: - o Iodosorb Gel cleared under 510(k) K905069, from Perstorp Pharmna. o Triosyn T40 Antimicrobial Dressing under 510(k) KO5 1452, from Triosyn Corporation… | 1991 |
| * | K051542 | Triosyn T40 Antimicrobial Wound Dressing Our reading of the summary gave K051452, FDA’s number for Sentinel Clin Chem Cal (Sentinel Ch. Srl). Corrected to the number with two digits swapped whose FDA name carries the summary’s words for the device, “Triosyn T40 Antimicrobial Dressing”. | 2006 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 16 years and passes through 3 companies; a new generation was cleared every 11.9 years on median.
- None of the 4 ancestors has a recall.
- 2 other devices also cite its predicate K905069.
How does its category compare?
All FRO devicesFRO Dressing, Wound, Drug: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.
FDA decisions per year · FRO
11in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · FRO
176in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · FRO
2in 2024
Class I (2 since 2007) Class II/III not classified
Adverse event reports per year · FRO
192in 2025
MAUDE reports naming product code FRO, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 29 | 187 | 4 | 55 |
| 2008 | 26 | 130 | 1 | 30 |
| 2009 | 31 | 136 | 1 | 45 |
| 2010 | 31 | 146 | 0 | 122 |
| 2011 | 27 | 177 | 4 | 42 |
| 2012 | 24 | 96 | 0 | 65 |
| 2013 | 19 | 194 | 1 | 139 |
| 2014 | 22 | 214 | 1 | 269 |
| 2015 | 28 | 249 | 2 | 297 |
| 2016 | 28 | 222 | 3 | 147 |
| 2017 | 23 | 147 | 1 | 149 |
| 2018 | 20 | 206 | 0 | 128 |
| 2019 | 16 | 270 | 1 | 136 |
| 2020 | 12 | 226 | 0 | 139 |
| 2021 | 8 | 275 | 6 | 183 |
| 2022 | 9 | 332 | 2 | 176 |
| 2023 | 18 | 283 | 2 (2) | 198 |
| 2024 | 24 | 263 | 2 | 232 |
| 2025 | 11 | 176 | 0 | 192 |
| 2026 | 17 | 254 | 2 | — |
What is it indicated for?
DryodineTM Antibacterial Gel is indicated for use in the management/cleaning of wet ulcers and wounds such as venous stasis ulcers, pressure sores, diabetic foot ulcers, and traumatic and surgical wounds. DryodineTm Antibacterial Gel assists to keep lesions soft and pliable.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K093320 · printed Nov 4, 2026
Cite this page
510(k) Report. “K093320: Dryodine Cadexomer-Iodine Gel.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K093320
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026